Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study.
about
Adalimumab: A Review in Chronic Plaque Psoriasis."Inflammatory skin march" in atopic dermatitis and psoriasis.Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1).Effects of maxacalcitol ointment on skin lesions in patients with psoriasis receiving treatment with adalimumab.
P2860
Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Adalimumab treatment optimizat ...... term phase 2/3 Japanese study.
@en
type
label
Adalimumab treatment optimizat ...... term phase 2/3 Japanese study.
@en
prefLabel
Adalimumab treatment optimizat ...... term phase 2/3 Japanese study.
@en
P2093
P2860
P356
P1476
Adalimumab treatment optimizat ...... term phase 2/3 Japanese study.
@en
P2093
Akihiko Asahina
Henrique D Teixeira
Hidemi Nakagawa
Mamitaro Ohtsuki
Martin M Okun
Takafumi Etoh
Yuji Yamaguchi
P2860
P304
P356
10.1111/1346-8138.13001
P577
2015-06-29T00:00:00Z